Literature DB >> 21926631

Incorporation of the HIV-1 microbicide cyanovirin-N in a food product.

Ming Li1, Dorothy L Patton, Yvonne Cosgrove-Sweeney, Deena Ratner, Lisa C Rohan, Alexander M Cole, Patrick M Tarwater, Phalguni Gupta, Bharat Ramratnam.   

Abstract

An urgent need exists for HIV-1 microbicides. Here, we describe the in vivo testing of lactic acid bacteria bioengineered to secrete cyanovirin-N. We fed pigtail macaques a yogurt formulation that used bioengineered strains as a starter culture. Cyanovirin-N expression could be detected in the rectal vault during and immediately after feeding. Ex vivo viral challenge of rectal tissue biopsies revealed that peak viral burden was significantly lower in tissue obtained from experimental animals compared with control animals. Formulation of candidate compounds in lactic acid bacteria and their oral administration seems to be a feasible strategy for mucosal delivery of microbicides.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21926631      PMCID: PMC3440868          DOI: 10.1097/QAI.0b013e31823643fe

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  19 in total

1.  Generation of food-grade recombinant lactic acid bacterium strains by site-specific recombination.

Authors:  M C Martín; J C Alonso; J E Suárez; M A Alvarez
Journal:  Appl Environ Microbiol       Date:  2000-06       Impact factor: 4.792

2.  Preexposure chemoprophylaxis for HIV prevention in men who have sex with men.

Authors:  Robert M Grant; Javier R Lama; Peter L Anderson; Vanessa McMahan; Albert Y Liu; Lorena Vargas; Pedro Goicochea; Martín Casapía; Juan Vicente Guanira-Carranza; Maria E Ramirez-Cardich; Orlando Montoya-Herrera; Telmo Fernández; Valdilea G Veloso; Susan P Buchbinder; Suwat Chariyalertsak; Mauro Schechter; Linda-Gail Bekker; Kenneth H Mayer; Esper Georges Kallás; K Rivet Amico; Kathleen Mulligan; Lane R Bushman; Robert J Hance; Carmela Ganoza; Patricia Defechereux; Brian Postle; Furong Wang; J Jeff McConnell; Jia-Hua Zheng; Jeanny Lee; James F Rooney; Howard S Jaffe; Ana I Martinez; David N Burns; David V Glidden
Journal:  N Engl J Med       Date:  2010-11-23       Impact factor: 91.245

3.  Protection of macaques from vaginal SHIV challenge by vaginally delivered inhibitors of virus-cell fusion.

Authors:  Ronald S Veazey; Per Johan Klasse; Susan M Schader; Qinxue Hu; Thomas J Ketas; Min Lu; Preston A Marx; Jason Dufour; Richard J Colonno; Robin J Shattock; Martin S Springer; John P Moore
Journal:  Nature       Date:  2005-10-30       Impact factor: 49.962

4.  Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: potential applications to microbicide development.

Authors:  M R Boyd; K R Gustafson; J B McMahon; R H Shoemaker; B R O'Keefe; T Mori; R J Gulakowski; L Wu; M I Rivera; C M Laurencot; M J Currens; J H Cardellina; R W Buckheit; P L Nara; L K Pannell; R C Sowder; L E Henderson
Journal:  Antimicrob Agents Chemother       Date:  1997-07       Impact factor: 5.191

5.  Inhibition of HIV infectivity by a natural human isolate of Lactobacillus jensenii engineered to express functional two-domain CD4.

Authors:  Theresa L-Y Chang; Chia-Hwa Chang; David A Simpson; Qiang Xu; Patrick K Martin; Laurel A Lagenaur; Gary K Schoolnik; David D Ho; Sharon L Hillier; Mark Holodniy; John A Lewicki; Peter P Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-12       Impact factor: 11.205

6.  Prevention of virus transmission to macaque monkeys by a vaginally applied monoclonal antibody to HIV-1 gp120.

Authors:  Ronald S Veazey; Robin J Shattock; Melissa Pope; J Christian Kirijan; Jennifer Jones; Qinxue Hu; Tom Ketas; Preston A Marx; Per Johan Klasse; Dennis R Burton; John P Moore
Journal:  Nat Med       Date:  2003-02-10       Impact factor: 53.440

7.  Cyanovirin-N inhibits AIDS virus infections in vaginal transmission models.

Authors:  Che-Chung Tsai; Peter Emau; Yonghou Jiang; Michael B Agy; Robin J Shattock; Ann Schmidt; William R Morton; Kirk R Gustafson; Michael R Boyd
Journal:  AIDS Res Hum Retroviruses       Date:  2004-01       Impact factor: 2.205

8.  Cyanovirin-N gel as a topical microbicide prevents rectal transmission of SHIV89.6P in macaques.

Authors:  Che-Chung Tsai; Peter Emau; Yonghou Jiang; Baoping Tian; William R Morton; Kirk R Gustafson; Michael R Boyd
Journal:  AIDS Res Hum Retroviruses       Date:  2003-07       Impact factor: 2.205

9.  MUC-2 mucin production in Hirschsprung's disease: possible association with enterocolitis development.

Authors:  Aladdein F Mattar; Arnold G Coran; Daniel H Teitelbaum
Journal:  J Pediatr Surg       Date:  2003-03       Impact factor: 2.545

10.  Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10.

Authors:  Lothar Steidler; Sabine Neirynck; Nathalie Huyghebaert; Veerle Snoeck; An Vermeire; Bruno Goddeeris; Eric Cox; Jean Paul Remon; Erik Remaut
Journal:  Nat Biotechnol       Date:  2003-06-15       Impact factor: 54.908

View more
  5 in total

1.  Carbohydrate recognition by the antiviral lectin cyanovirin-N.

Authors:  Yukiji K Fujimoto; David F Green
Journal:  J Am Chem Soc       Date:  2012-11-20       Impact factor: 15.419

2.  Engineering soya bean seeds as a scalable platform to produce cyanovirin-N, a non-ARV microbicide against HIV.

Authors:  Barry R O'Keefe; André M Murad; Giovanni R Vianna; Koreen Ramessar; Carrie J Saucedo; Jennifer Wilson; Karen W Buckheit; Nicolau B da Cunha; Ana Claudia G Araújo; Cristiano C Lacorte; Luisa Madeira; James B McMahon; Elibio L Rech
Journal:  Plant Biotechnol J       Date:  2015-01-09       Impact factor: 9.803

Review 3.  Antiviral lectins: Selective inhibitors of viral entry.

Authors:  Carter A Mitchell; Koreen Ramessar; Barry R O'Keefe
Journal:  Antiviral Res       Date:  2017-03-18       Impact factor: 5.970

Review 4.  An update of the recombinant protein expression systems of Cyanovirin-N and challenges of preclinical development.

Authors:  Hajie Lotfi; Roghayeh Sheervalilou; Nosratollah Zarghami
Journal:  Bioimpacts       Date:  2017-11-16

Review 5.  Antiviral Cyanometabolites-A Review.

Authors:  Hanna Mazur-Marzec; Marta Cegłowska; Robert Konkel; Krzysztof Pyrć
Journal:  Biomolecules       Date:  2021-03-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.